Current stock page

Catalysts

EXAS Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - Diagnostics & ResearchScore data as of Oct 21, 2026

EXASExact Sciences Corporation

Healthcare / Medical - Diagnostics & Research

Low Priority

Relative Laggard

NeutralEdge 3/10
—

Latest quote

  • Momentum
    —
  • Value
    37
  • Quality
    44
  • Risk resilience
    67
  • Sentiment
    —
algovestiq.comScore data as of Oct 21, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
—

No upcoming reporting date is available yet.

AIQ Catalyst
AIQ 46/100

Momentum — and sentiment — before the next covered event.

Recent coverage
3 articles

Updated Oct 21, 2026 · Sentiment 26.58%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum —AIQ Edge 3/10 Relative Laggard
Beat rate
50%
3 of 6 reported periods
Average surprise
+233.5%
Across covered historical reports
Latest result
-316.9%
Feb 13, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Feb 13, 2026—-$0.11-$0.45-316.9%$860.9M$878.38M
Nov 3, 2025—-$0.06$0.24+492.0%$810.51M$850.74M
Aug 6, 2025—-$0.02$0.22+1200.0%$810.06M$811.09M
May 1, 2025—-$0.37-$0.54-45.9%$688.65M$706.79M
Feb 19, 2025—-$0.29-$0.06+79.3%$697.89M$713.42M
Nov 5, 2024—-$0.20-$0.21-7.2%$716.8M$708.66M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Hold
2
Buy
20
Hold
12-month analyst target
$105.00
— versus current price
Based on 1 analyst observations. Targets are estimates, not predictions.
Low target
$105.00
—
Average target
$105.00
—
High target
$105.00
—

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event date—

Upcoming earnings date not available yet.

EPS estimate-$0.36

Current analyst expectation for the upcoming report.

Revenue estimate$952.94K

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score—

Where event reaction would show up first.

AIQ score46/100

Composite decision read before event confirmation.

Analyst context

Consensus
Hold
Analysts
1
Average target
$105.00
Target range
$105.00 - $105.00
90-day revisions
0

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
2
Neutral
0
Negative
1
insidermonkey.com · Oct 20, 2026

Abbott (ABT): Can Libre Keep Growing as Glucose Monitoring Becomes More Competitive?

Abbott Laboratories (NYSE:ABT) benefits each time a patient replaces a glucose sensor.

gurufocus.com · Sep 28, 2026

Humacyte (HUMA) Adds Scott Coward and Paul Kuznik to Board of Directors

On September 28, 2026, Humacyte Inc (NASDAQ: HUMA) announced the appointment of Scott Coward and Paul Kuznik to its Board of Directors, signaling a strategic mo

markets.businessinsider.com · Aug 13, 2026

Mdxhealth Reports Second Quarter 2026 Financial Results

Second quarter revenue growth of16% to $27.2 millionConference call with Q&A today at 4:30 PM EST / 22:30 CETIRVINE, California –August13, 202...

Open full news and sentiment

EXAS Catalysts FAQ

What are the next catalysts for EXAS stock?

EXAS's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move EXAS stock?

Upcoming events that could move EXAS include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could EXAS's next earnings report affect the stock?

EXAS's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive EXAS stock higher?

EXAS could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt EXAS stock?

EXAS could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.